Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question 💭
Durban, ZA
May 2, 2025
 · 
Be the first to react
MyLymphomaTeam

Primary mediastinal large B-cell lymphoma (PMBCL) is a type of non-Hodgkin lymphoma that develops from immune system cells called B lymphocytes. This rare cancer primarily forms in the mediastinum, which is the space between the lungs. It accounts for only 2-4% of all non-Hodgkin lymphomas and most commonly affects young Show Full Answer

Primary mediastinal large B-cell lymphoma (PMBCL) is a type of non-Hodgkin lymphoma that develops from immune system cells called B lymphocytes. This rare cancer primarily forms in the mediastinum, which is the space between the lungs. It accounts for only 2-4% of all non-Hodgkin lymphomas and most commonly affects young adults, particularly women, though it can also occur in children. Most people with PMBCL develop a large tumor (greater than 10 centimeters) in the early stages of the disease. Common symptoms include difficulty swallowing, rapid breathing, coughing, and blood clots in the veins. Many patients also experience vena cava syndrome, which can cause breathing difficulties, facial and abdominal swelling, and visible large veins in the chest. Diagnosis typically involves lymph node biopsy, where tissue is removed either through surgery or needle biopsy to examine for cancer cells. Doctors may also perform bone marrow testing to determine if the disease has spread. When viewed under a microscope, PMBCL cancer cells share characteristics with both classical Hodgkin lymphoma and diffuse large B-cell lymphoma (DLBCL).

May 2, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Durban, ZA

A MyLymphomaTeam Member asked a question 💭
Cleveland, OH